Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
124I-Metaiodobenzylguanidine (MIBG) (no-carrier added)
124I-MIBG (carrier added)
+1 more
Locations
1
United States
University of California, San Francisco
San Francisco, California, United States
Start Date
April 9, 2013
Primary Completion Date
February 25, 2021
Completion Date
February 25, 2021
Last Updated
May 14, 2021
NCT03050268
NCT04308330
NCT06721689
NCT06395103
NCT06541262
NCT06057948
Lead Sponsor
Miguel Pampaloni
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions